@misc{indiciaef7cbe4633b2a,
  title = {Targeting the Atypical Chemokine Receptor 2 (ACKR2) improves the benefit of anti-PD-1 immunotherapy in melanoma},
  author = {Noman, M. Z. and Szpakowska, M. and Xiao, M. and Van Moer, K. and Ollert, M. and Berchem, G. and Chevigne, A. and Janji, B.},
  year = {2024},
  doi = {10.1101/2024.04.02.587761},
  url = {https://www.biorxiv.org/content/10.1101/2024.04.02.587761v1},
  note = {Source identifier: 10.1101/2024.04.02.587761}
}